CD163 is a macrophage receptor that clears hemoglobin-haptoglobin complexes from blood, preventing oxidative damage and also ...

A natural antibacterial molecule shows clinical promise. Its unusual binding site is on an excellent target: ...

Scientists have discovered more than a dozen genes that regulate the production of fetal hemoglobin in people of African ...

A super-resolution microscopy technique offers an unparalleled glimpse into how monoclonal antibodies bind to their targets ...

Scientists say they have identified a potential new gene target that could be edited to treat sickle cell disease, an ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...

Scientists have found a potential new gene variant target to treat sickle cell disease, an inherited blood disorder that ...

Drugs and other treatments can be quite effective at killing cancer cells, yet many fall short as they struggle to penetrate ...

Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders ...

Prevention is the best medicine.   While not all chronic diseases can be prevented, one of the best ways to stay ...

While not all chronic diseases can be prevented, one of the best ways to stay healthy is to take preventive health care ...